Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1935

1.
2.

Unloading therapy by intravenous diuretic in chronic heart failure: a double-edged weapon?

De Vecchis R, Ciccarelli A, Pucciarelli A.

J Cardiovasc Med (Hagerstown). 2010 Aug;11(8):571-4. doi: 10.2459/JCM.0b013e32833d37b9. Review.

PMID:
20588135
3.

Prevalence, predictors and prognostic value of acute impairment in renal function during intensive unloading therapy in a community population hospitalized for decompensated heart failure.

Cioffi G, Tarantini L, Pulignano G, Del Sindaco D, De Feo S, Opasich C, Dilenarda A, Stefenelli C, Furlanello F.

J Cardiovasc Med (Hagerstown). 2007 Jun;8(6):419-27.

PMID:
17502758
5.

Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.

Licata G, Di Pasquale P, Parrinello G, Cardinale A, Scandurra A, Follone G, Argano C, Tuttolomondo A, Paterna S.

Am Heart J. 2003 Mar;145(3):459-66.

PMID:
12660669
6.
7.

Clinical experience with low-dose continuous infusion of furosemide in acute heart failure: assessment of efficacy and safety.

Ng TM, Hshieh S, Chan CY, Elkayam U.

J Cardiovasc Pharmacol Ther. 2012 Dec;17(4):373-81. doi: 10.1177/1074248412446194. Epub 2012 May 18.

PMID:
22610091
8.

ACE-inhibitor therapy at relatively high doses and risk of renal worsening in chronic heart failure.

De Vecchis R, Di Biase G, Ariano C, Cioppa C, Giasi A, Ciccarelli A, Pucciarelli A, Cantatrione S.

Arq Bras Cardiol. 2011 Dec;97(6):507-16. Epub 2011 Oct 14. English, Portuguese.

9.

How prevalent is hyperkalemia and renal dysfunction during treatment with spironolactone in patients with congestive heart failure?

Svensson M, Gustafsson F, Galatius S, Hildebrandt PR, Atar D.

J Card Fail. 2004 Aug;10(4):297-303.

PMID:
15309695
11.

Continuous infusion of furosemide combined with low-dose dopamine compared to intermittent boluses in acutely decompensated heart failure is less nephrotoxic and carries a lower readmission at thirty days.

Aziz EF, Alviar CL, Herzog E, Cordova JP, Bastawrose JH, Pamidimukala CK, Tojino A, Park TS, Musat D, Kukin M.

Hellenic J Cardiol. 2011 May-Jun;52(3):227-35.

12.

Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure.

Veeraveedu PT, Watanabe K, Ma M, Palaniyandi SS, Yamaguchi K, Kodama M, Aizawa Y.

Biochem Pharmacol. 2008 Mar 15;75(6):1322-30. doi: 10.1016/j.bcp.2007.11.011. Epub 2007 Dec 3.

PMID:
18179782
13.

Antigen carbohydrate 125 and creatinine on admission for prediction of renal function response following loop diuretic administration in acute heart failure.

Núñez J, Llàcer P, Núñez E, Ventura S, Bonanad C, Bodí V, Miñana G, Santas E, Mascarell B, Fonarow GC, Chorro FJ, Sanchis J.

Int J Cardiol. 2014 Jul 1;174(3):516-23. doi: 10.1016/j.ijcard.2014.04.113. Epub 2014 Apr 18.

PMID:
24801083
14.

Effect of admission oral diuretic dose on response to continuous versus bolus intravenous diuretics in acute heart failure: an analysis from diuretic optimization strategies in acute heart failure.

Shah RV, McNulty S, O'Connor CM, Felker GM, Braunwald E, Givertz MM.

Am Heart J. 2012 Dec;164(6):862-8. doi: 10.1016/j.ahj.2012.08.019. Epub 2012 Oct 29.

15.

Risk factors for acute renal insufficiency induced by diuretics in patients with congestive heart failure.

Sun WY, Reiser IW, Chou SY.

Am J Kidney Dis. 2006 May;47(5):798-808.

PMID:
16632018
16.

Diuretic strategies in patients with acute decompensated heart failure.

Felker GM, Lee KL, Bull DA, Redfield MM, Stevenson LW, Goldsmith SR, LeWinter MM, Deswal A, Rouleau JL, Ofili EO, Anstrom KJ, Hernandez AF, McNulty SE, Velazquez EJ, Kfoury AG, Chen HH, Givertz MM, Semigran MJ, Bart BA, Mascette AM, Braunwald E, O'Connor CM; NHLBI Heart Failure Clinical Research Network.

N Engl J Med. 2011 Mar 3;364(9):797-805. doi: 10.1056/NEJMoa1005419.

17.

Predisposing factors for acute kidney injury in Hispanic patients treated with diuretics for decompensated heart failure.

Ricci F, Ramírez T, Marmorato R, Vega J, Pagán P, López JE, Soto-Salgado M, Cangiano JL.

P R Health Sci J. 2013 Jun;32(2):63-7.

PMID:
23781621
18.

Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure.

Weinfeld MS, Chertow GM, Stevenson LW.

Am Heart J. 1999 Aug;138(2 Pt 1):285-90.

PMID:
10426840
19.

[Renoprotective effect of small volumes of hypertonic saline solution in chronic heart failure patients with marked fluid retention: results of a case-control study].

De Vecchis R, Ciccarelli A, Ariano C, Pucciarelli A, Cioppa C, Giasi A, Fusco A, Cantatrione S.

Herz. 2011 Feb;36(1):12-7. doi: 10.1007/s00059-010-3394-3. Epub 2010 Oct 28. German.

PMID:
20978728
20.

Differential mortality association of loop diuretic dosage according to blood urea nitrogen and carbohydrate antigen 125 following a hospitalization for acute heart failure.

Núñez J, Núñez E, Miñana G, Bodí V, Fonarow GC, Bertomeu-González V, Palau P, Merlos P, Ventura S, Chorro FJ, Llàcer P, Sanchis J.

Eur J Heart Fail. 2012 Sep;14(9):974-84. doi: 10.1093/eurjhf/hfs090. Epub 2012 Jun 14.

Supplemental Content

Support Center